Confidential Materials omitted and filed separately with the6 to Agreement • February 16th, 2018 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 16th, 2018 Company IndustryTHIS AMENDMENT NO.6 TO AGREEMENT (this “Amendment”) is made effective as of January 1, 2017, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 east Shelby Drive, Memphis Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).